STADA Pymepharco x Trung Son Pharma: Strategic Partnership to enhance pharmaceutical access in Vietnam

Ho Chi Minh City, 13 February 2025 | STADA Pymepharco, – one of leading pharmaceutical companies in Vietnam and the sole wholly affiliate member of STADA Group (Germany) since 2021, has entered a strategic partnership through a Memorandum of Understanding (MOU) with Trung Son Pharma, one of the country’s largest and most trusted retail pharmacy chains. The signing ceremony, held at STADA Pymepharco’s Representative Office in Ho Chi Minh City, marks a significant milestone as the two companies join forces to strengthen medicine accessibility across Vietnam.

Serving STADA Group’s global purpose of “Caring for People’s Health as a Trusted Partner”, this collaboration strengthens STADA Pymepharco’s commitment to improving domestic access to high-quality pharmaceutical products. The strategic partnership also aims to ensure the supply continuity of international superior “German standard” healthcare solutions to Vietnam population while expanding STADA Pymepharco’s global footprint.

By aligning with STADA Pymepharco, this partnership represents Trung Son Pharma’s strategic step toward its long-term vision of becoming Vietnam’s most trusted pharmacy chain, providing safe, high-quality, and affordable healthcare solutions to communities across the country.

A Milestone in Vietnam’s Pharmaceutical Retail Industry  

The partnership between STADA Pymepharco and Trung Son Pharma is set to enhance the availability of essential healthcare products through its extensive retail network. This collaboration will focus on expanding access to STADA’s and STADA Pymepharco’s diverse Consumer Healthcare and Generics portfolio, including pain management (Analgesics, Mouth pain, Ant varicose), Gastroenterology (Liver care), Weight loss, Cough Cold Allergy, high-quality vitamins, minerals & supplements (VMS), functional supplements (FS), antibiotics, and cardiovascular care etc., among others. Beyond medicine supply, we will also collaborate on pharmacist training to enhance consultation quality and outpatient treatment. Education programs for patient and community will also be prioritized as we strive to raise public awareness of preventive healthcare and treatment.

By leveraging Trung Son’s market reach and combining with STADA Pymepharco global expertise and local insights in pharmaceuticals, the partnership aims to improve healthcare accessibility while delivering safe, effective, and affordable medicines to consumers and patients across Vietnam.  

Through diversifying Trung Son’s portfolio with internationally recognized pharmaceutical products from STADA Pymepharco, this collaboration is expected to drive growth, innovation, and operational excellence, enabling both companies to further solidify its position as one of the leading pharmaceutical manufacturers and retail pharmacy chains in Vietnam. 

Speaking at the signing ceremony, Mr. Philippe Gautron, General Manager of STADA Pymepharco, emphasized: “This strategic partnership with Trung Son represents an important step in our ongoing commitment to bringing international superior quality healthcare products to citizens in Vietnam. By combining STADA Pymepharco’s global best practices, rich heritage and local insights in pharmaceutical manufacturing with Trung Son’s well-established retail network, we are confident that this collaboration will make a positive impact on public health in Vietnam as our innovative healthcare solutions reach a broader segment of the population. I believe this partnership aligns with our global vision to lead in both growth and profitability, as we aim to set new benchmarks in pharmaceutical accessibility and quality across the nation”.

Mr. Roh Woong Ho, CEO of Trung Son Pharma shared his perspective: "We are delighted to join hands with STADA Pymepharco, a company known for its commitment in caring for people’s health with global healthcare standards. This partnership aligns with Trung Son’s mission to provide customers with the best pharmaceutical products and services, ensuring that every Vietnamese household has access to trusted, superior international medicines. Beyond strengthening our product portfolio offered at our pharmacy chain, we view this collaboration as an opportunity to drive innovation, enhance operational excellence, and adopt global best practices in pharmaceutical retail".  

Commitment to Long-Term Development and Innovation  

The formalization of this strategic partnership not only underscores both companies’ shared vision for long-term collaboration but also sets the stage for continued innovation in Vietnam’s pharmaceutical sector. With STADA Pymepharco’s EU -GMP-certified manufacturing facilities in Tuy Hoa, Phu Yen and Trung Son’s robust pharmacy network across the nation, the partnership is expected to expand consumer access to high-quality healthcare solutions, strengthening Vietnam’s healthcare ecosystem.  As we enter this new chapter in Vietnam’s pharmaceutical industry, STADA Pymepharco and Trung Son’s shared goals are significantly reinforced in terms of promoting healthcare accessibility and quality for the Vietnam population.

About STADA Pymepharco:

STADA Pymepharco began its journey in 1989 and became a part of the STADA Group in 2021, making us the sole STADA wholly owned STADA member in Vietnam. As one of the country’s leading pharmaceutical manufacturers, we are part of a global pharmaceutical leader with nearly 130 years of heritage.

• 2 EU-GMP-certified manufacturing plants in Tuy Hoa, Phu Yen, each with an annual capacity of nearly 1.5 billion units.
• 1200++ employees nationwide
• 27,000 SKUs worldwide with 8,000 Consumer Healthcare (CHC) products.
• 400 SKUs in our portfolio in Vietnam – including 250 Generics (Rx) and 150 CHC, of which around 80 products are assessed as bioequivalents to innovator medicines.
• Trusted by over 14,000 customers and partners, including hospitals, medical facilities, pharmacies, pharmacy chains and other pharmaceutical businesses.

About Trung Son Pharma:   

Established in 1997, Trung Son Pharma has grown into one of Vietnam’s most reputable pharmacy networks, with over 350 retail pharmacies primarily in Vietnam's Southern region [2025] and more than 3 million members, with a strong presence in Can Tho City. The company offers a wide range of healthcare products, including prescription and over-the-counter medications, health supplements, cosmetics, and medical equipment. Trung Son Pharma is committed to offering safe, high-quality, and affordable pharmaceutical products, ensuring better healthcare access for Vietnamese communities. In 2023, the company strengthened its position in the market by forming a strategic alliance with Dongwha Pharm, a leading South Korean pharmaceutical company, further boosting its growth and innovation capabilities.  With a strong focus on customer care and professional service, Trung Son continues to expand its reach, ensuring high-quality healthcare solutions are accessible to communities nationwide.  

---------------------------------------------------------

For further media inquiries, please contact:  

Public Affairs and Communications Department – STADA Pymepharco  

Hoang Le Thanh An (Ms.) – Public Affairs and Communications Manager  

Email: an.hoanglethanh@stada.com